ResMed Announces Participation in the UBS Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) announced that Chairman and CEO Mick Farrell and Chief Medical Officer Dr. Carlos Nunez will participate in a fireside chat at the UBS Global Healthcare Conference. The event will take place on November 12, 2024, at 3:30 p.m. PST at the Terranea Resort Hotel in Rancho Palos Verdes, CA. A live audio-only webcast will be available on the investor relations website, with a replay accessible for 30 days following the event.
ResMed (NYSE: RMD, ASX: RMD) ha annunciato che il Presidente e CEO Mick Farrell e il Direttore Medico Dr. Carlos Nunez parteciperanno a una chiacchierata informale durante la Conferenza Globale sulla Salute di UBS. L'evento si terrà il 12 novembre 2024, alle 15:30 PST, presso il Terranea Resort Hotel a Rancho Palos Verdes, CA. Sarà disponibile una trasmissione audio in diretta sul sito web delle relazioni con gli investitori, con una registrazione accessibile per 30 giorni dopo l'evento.
ResMed (NYSE: RMD, ASX: RMD) anunció que el Presidente y CEO Mick Farrell y el Director Médico Dr. Carlos Nunez participarán en una charla informal en la Conferencia Global de Salud de UBS. El evento se llevará a cabo el 12 de noviembre de 2024, a las 3:30 p.m. PST en el Terranea Resort Hotel en Rancho Palos Verdes, CA. Habrá una transmisión en vivo solo de audio disponible en el sitio web de relaciones con inversores, con una repetición accesible durante 30 días tras el evento.
ResMed (NYSE: RMD, ASX: RMD)는 의장 겸 CEO인 Mick Farrell과 최고 의료 책임자 Dr. Carlos Nunez가 UBS 글로벌 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 이 행사는 2024년 11월 12일 오후 3시 30분 PST에 Terranea Resort Hotel에서 열릴 예정입니다. 투자자 관계 웹사이트에서 오디오 전용 실시간 웹캐스트가 제공되며, 이벤트 이후 30일 동안 Replay를 이용할 수 있습니다.
ResMed (NYSE: RMD, ASX: RMD) a annoncé que le président et PDG Mick Farrell et le directeur médical Dr. Carlos Nunez participeront à une discussion informelle lors de la Conférence Mondiale sur la Santé de l'UBS. L'événement aura lieu le 12 novembre 2024 à 15h30 PST à l'Hôtel Terranea Resort à Rancho Palos Verdes, CA. Un webcast audio en direct sera disponible sur le site web des relations avec les investisseurs, avec un enregistrement accessible pendant 30 jours après l'événement.
ResMed (NYSE: RMD, ASX: RMD) hat angekündigt, dass der Vorsitzende und CEO Mick Farrell sowie der Chief Medical Officer Dr. Carlos Nunez an einem informellen Gespräch auf der UBS Global Healthcare Conference teilnehmen werden. Die Veranstaltung findet am 12. November 2024 um 15:30 Uhr PST im Terranea Resort Hotel in Rancho Palos Verdes, CA, statt. Eine Live-Audioübertragung wird auf der Webseite für Investorenbeziehungen verfügbar sein, mit einer Wiederholung, die 30 Tage nach der Veranstaltung abgerufen werden kann.
- None.
- None.
SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at approximately 3:30 p.m. (Pacific Standard Time) at the Terranea Resort Hotel in Rancho Palos Verdes, CA.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media | |
| +1 858.836.5000 | +1 619.510.1281 | |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When is ResMed (RMD) presenting at the UBS Global Healthcare Conference 2024?
Who will represent ResMed (RMD) at the UBS Global Healthcare Conference 2024?
How long will ResMed's (RMD) UBS conference webcast replay be available?
